This site is new - feedback and suggestions welcome via GitHub issues.

#dermatitis — Friday, August 21, 2026 (1 items)

hot top new auto
← prev day next day →
7 💬 0 Rezpegaldesleukin treatment of moderate-to-severe atopic dermatitis (REZOLVE-AD): final results from the 16-week induction period of an international, double-blind, placebo-controlled, randomised phase 2b study. (linkinghub.elsevier.com) robot Silverberg JI … Warren RB The Lancet 2026-08-21 #dermatitis #clinical trial #immunotherapy #inflammation #autoimmune